본문 바로가기
KERD
논문KCI 등재

Remission of intestinal Beh？et's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)

Young Ran Shim|Byung Ik Jang|Tae Nyeun Kim|Jung Hoon Lee|Sun Taek Choi|Kyeong cheol Shin|Sam Beom Lee
대한내과학회 (The Korean Association Of Internal Medicine)|2007.03|The Korean Journal of Internal Medicine|제22권 제1호|pp. 24-27

1

조회

0

다운로드

7

인용

0

참고문헌

주제분류내과학

초록

Abstract

Behçet's disease (BD) is a chronic relapsing multisystem disease characterized by oral ulceration, genital ulceration and ocular lesions. Gastrointestinal involvement is rare, often difficult to treat and associated with a high mortality rate. We treated a 47-year-old Korean man with BD who had a recurrent intestinal ulcer with tumor necrosis factor α antibody (infliximab); he initially underwent right hemicolectomy due to uncontrolled intestinal bleeding. For patients with intestinal BD who fail to respond to conventional treatment, infliximab may be a safe and effective new therapeutic option.

참고문헌 (19)

  1. "Ueber rezidivierende aphtese durch ein virus verusachte Geswuere am Mund, am Auge und an den Genitalien", pp.1152~1157 (1937)
  2. "Behet's disease", 341, pp.1284~1291 (1999)
  3. "Gastrointestinal manifestations of Behcet's disease", 30, pp.144~154 (2000)
  4. "Treatment of intestinal Behet's syndrome with chimeric tumour necrosis factor alpha antibody", 49, pp.725~728 (2001)
  5. "Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case", 46, pp.118~121 (2003)
  6. "Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)", pp.843~846 (1979)
  7. "Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1" (1980)
  8. "Maeda S. A case of Behcet's disease with multiple longitudinal ulcers all over the colon. Am J Gastroenterol 89", pp.778~780 (1994)
  9. "Long-term clinical course and prognostic factors in intestinal Behcet's disease", 43, pp.692~700 (2000)
  10. "Behet's disease: an update on the pathogenesis", 19, pp.S6~S12 (2001)
  11. "Mizushima Y. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet's disease. J Rheumatol 19", pp.588~592 (1992)
  12. "Role of gammadelta T lymphocytes in the development of Behcet's disease", 107, pp.241~247 (1997)
  13. "Behcet's disease: a new target for anti-tumour necrosis factor treatment", 61, pp.ii51~ii53 (2002)
  14. "Response to medical therapy, course and recurrence of colonic lesions in behcet's colitis", 30, pp.472~480 (1997)
  15. "Intestinal involvement in Behcet's disease: review of 136 surgical cases in the Japanease literature", nishi(m), pp.103~106 (1981)
  16. "International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 335", pp.1078~1080 (1990)
  17. "Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with Infliximab", 40, pp.473~474 (2001)
  18. "Effect of infliximab on threatening panuveitis in Behcet's disease", 358, pp.1644~ (2001)
  19. "Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report", 120, pp.995~999 (2001)

관련 논문AI추천

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease박지혜, 천재희거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제6호Updated treatment strategies for intestinal Behçet’s disease천재희, Yong Eun Park대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제1호Efficacy and Safety of Anti-Tumor Necrosis Factor- Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-AnalysisChunyan Ma, Meiqi Li, Qingfeng Zhang, Qingrui Yang, Rongrong Dong, Weizhen Xiang, Zhenzhen Ma연세대학교의과대학 · Yonsei Medical Journal2022 · 제63권 제2호Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)김주성, 송근암, 신성재, Cheon Jae Hee, Han Dong Soo, Kim Hyun-Soo, Kim Sung Kook, Kim Won Ho, Kim Youngdoe, Lee Yoosun, Lee YoungJa, Ye Byong Duk거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제5호Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy강은애, 김원호, 김태일, 박수정, 박재준, 박지혜, 천재희, 한소정연세대학교의과대학 · Yonsei Medical Journal2023 · 제64권 제2호Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?천재희, Park Jihye거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제5호

이 간행물의 다른 논문 (7건)

Volatile Organic Compounds Contribute to Airway Hyperresponsiveness박춘식, 장안수, 고영일, 최인선pp. 8-12A Case of Pulmonary Vein Tumor Presenting as a Left Atrial MassWook Jin Chung, Gwon Hyun Cho, Hyo Keun Jeon, Sun Young Kyung, Sung Hwan Jeong, Na Rae Kim, 김정호pp. 32-36Use of Tadalafil for Treating Pulmonary Arterial Hypertension Secondary to Chronic Obstructive Pulmonary DiseaseHyun-Sook Kim, 박성주, 박종관, 이흥범, Jae-Hyeong Parkpp. 37-39A Case of McCune-Albright Syndrome with Associated Multiple EndocrinopathiesHong Tae Kim, Ho Sang Shon, Hyun Dae Yoon, Sang Hun Sung, Joo Hyoung Lee, 서창진, Woo Young Choipp. 45-50Paroxysmal Autonomic Dysregulation with Fever that was Controlled by Propranolol in a Brain Neoplasm Patient송은기, Su Jin Oh, Yun Kyung Hongpp. 51-54
원문 보기